Table 6.
Patient distribution in the training and validation cohorts for insulin-like growth factor 1 score class by Child-Turcotte-Pugh score class*
| Patient cohort | IGF-CTP score | CTP score, No. (%) | ||
|---|---|---|---|---|
| A (5–6) | B (7–9) | C (>10) | ||
| Training cohort (n = 310) | A (4–5) | 158 (72.1) | 28 (38.4) | 0 |
| B (6–7) | 58 (26.5) | 28 (38.4) | 1 (14.3) | |
| C (>7) | 3 (1.4) | 17 (23.2) | 6 (85.7) | |
| Validation cohort (n = 155) | A (4–5) | 67 (53.2) | 3 (12.0) | 0 |
| B (6–7) | 58 (46.0) | 12 (48.0) | 0 | |
| C (>7) | 1 (0.8) | 10 (40.0) | 4 | |
* Notably, a substantial number of patients categorized under original Child-Turcotte-Pugh (CTP) class A moved to class B under the new insulin-like growth factor (IGF) scoring system: 58 of 219 patients (26.5%) in the training cohort, 58 of 126 patients (46%) in the validation cohort.